Brief Report: Recovery of Bone Mineral Density after Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis

• Main Authors: David V. Glidden, Kathleen Mulligan, Vanessa McMahan, Peter L. Anderson, Juan Guanira, Suwat Chariyalertsak, Susan P. Buchbinder, Linda Gail Bekker, Mauro Schechter, Beatriz Grinsztejn, Robert M. Grant
• 格式: 雜誌
• 出版: 2018
• 主題: Medicine
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85021110292&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/57608

© Copyright 2017 The Author(s). Published by Wolters Kluwer Health, Inc. Background: Oral tenofovir disoproxil fumarate (TDF) for HIV prevention and treatment is associated with decreases in bone mineral density (BMD). Previous reports suggest that these changes may be reversible after discontinuati...